New Atmosphere, New Vision: Gibson and Whittemore Kick Off Invest in ME Conference 2016
Mark Berry reports on Dr. Gibson's introduction and Dr. Whittemore's keynote speech, at the 11th Invest in ME International ME Conference in London.
Discuss the article on the Forums.

(US) Contact Your Federal Legislator and Make Your Voice Heard about Specialty Tiers!

Discussion in 'Action Alerts and Advocacy' started by *GG*, Apr 18, 2012.

  1. *GG*

    *GG* Senior Member

    Messages:
    5,177
    Likes:
    2,302
    Concord, NH
    Advocacy Call to Action:
    A number of health insurance companies throughout

    the country are adopting a new specialty tier pricing system for expensive drugs, requiring patients to pay much more for life-saving and disease-stabilizing medications. Insurers are abandoning the traditional arrangement where patients pay a fixed co-pay amount and instead charging patients a percentage of the cost of certain high-priced drugs, usually 25 to 33 percent, which can amount to thousands of dollars a month for vital medications.

    The Patients' Access to Treatments Act of 2012 (H.R. 4209) was introduced in March by US House of Representatives David McKinley (R-WV) and Lois Capps (D-CA) to address this important issue. H.R. 4209 requires health insurers to place specialty drugs within the same classification as Tier III non-preferred drugs. It would allow people living with serious devastating health conditions to continue to have access to the critical treatments which they need in order to live active and productive lives.

    Click here to find your House Representative

    http://www.house.gov/representative...ril_2012_FM_CP_Advocate_Copy&utm_medium=email

    Read the complete article and available template letter.

    http://fmcpaware.org/specialty-tier...ril_2012_FM_CP_Advocate_Copy&utm_medium=email
     

See more popular forum discussions.

Share This Page